Taller women are at greater risk of recurrent venous thromboembolism: The Iowa Women's Health Study

American Journal of Hematology

Volumn 87, Issue 7, 2012, Pages 716-717

  Lutsey, Pamela L ^a   Folsom, Aaron R ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; BODY HEIGHT; DISEASE ASSOCIATION; FEMALE; HUMAN; LEG LENGTH; LETTER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; RISK ASSESSMENT; UNITED STATES; VENOUS THROMBOEMBOLISM; WAIST CIRCUMFERENCE; WOMEN'S HEALTH;

AGED; AGED, 80 AND OVER; BODY HEIGHT; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IOWA; MEDICARE; PREVALENCE; PROPORTIONAL HAZARDS MODELS; QUESTIONNAIRES; RECURRENCE; RISK FACTORS; UNITED STATES; VENOUS THROMBOEMBOLISM;

EID: 84862522292     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23199     Document Type: Letter

References (24)

1. Lutsey PL, Virnig BA, Durham SB, et al. Correlates and consequences of venous thromboembolism: The Iowa Women's Health Study. Am J Public Health 2010; 100: 1506-1513.
2. Heit JA, Mohr DN, Silverstein MD, et al. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: A population-based cohort study. Arch Intern Med 2000; 160: 761-768.
3. Laczkovics C, Grafenhofer H, Kaider A, et al. Risk of recurrence after a first venous thromboembolic event in young women. Haematologica 2007; 92: 1201-1207.
4. White RH. The epidemiology of venous thromboembolism. Circulation 2003; 107: I-4-I-8.
5. Douketis JD, Gu CS, Schulman S, et al. The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism. Ann Intern Med 2007; 147: 766-774.
6. Kyrle PA, Rosendaal FR, Eichinger S. Risk assessment for recurrent venous thrombosis. Lancet 2010; 376: 2032-2039.
7. Rodger M, Carrier M, Gandara E, et al. Unprovoked venous thromboembolism: short term or indefinite anticoagulation? Balancing long-term risk and benefit. Blood Rev 2010; 24: 171-178.
8. Baglin T. Unprovoked deep vein thrombosis should be treated with long-term anticoagulation-No. J Thromb Haemost 2007; 5: 2336-2339.
9. Kearon C. Indefinite anticoagulation after a first episode of unprovoked venous thromboembolism: Yes. J Thromb Haemost 2007; 5: 2330-2335.
10. Zhu T, Martinez I, Emmerich J. Venous Thromboembolism: Risk factors for recurrence. Arterioscler Thromb Vasc Biol 2009; 29: 298-310.
11. Eichinger S, Heinze G, Jandeck LM, et al. Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: The Vienna prediction model. Circulation 2010; 121: 1630-1636.
12. Glynn RJ, Rosner B. Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism. Am J Epidemiol 2005; 162: 975-982.
13. Braekkan SK, Borch KH, Mathiesen EB, et al. Body height and risk of venous thromboembolism: The Tromso Study. Am J Epidemiol 2010; 171: 1109-1115.
14. Severinsen M, Johnsen S, Tjønneland A, et al. Body height and sex-related differences in incidence of venous thromboembolism: A Danish follow-up study. Eur J Intern Med 2010; 21: 268-272.
15. Rosengren A, Freden M, Hansson P-O, et al. Psychosocial factors and venous thromboembolism: A long-term follow-up study of Swedish men. J Thromb Haemost 2008; 6: 558-564.
16. Pomp ER, Le Cessie S, Rosendaal FR, et al. Risk of venous thrombosis: Obesity and its joint effect with oral contraceptive use and prothrombotic mutations. Br J Haematol 2007; 139: 289-296.
17. Lutsey PL, Cushman M, Heckbert SR, et al. Longer legs are associated with greater risk of incident venous thromboembolism independent of total body height. The Longitudinal Study of Thromboembolism Etiology (LITE). Thromb Haemost 2011; 106: 113-120.
18. Kugler C, Strunk M, Rudofsky G. Venous pressure dynamics of the healthy human leg. J Vasc Res 2001; 38: 20-29.
19. Fronek A, Criqui MH, Denenberg J, et al. Common femoral vein dimensions and hemodynamics including Valsalva response as a function of sex, age, and ethnicity in a population study. J Vasc Surg 2001; 33: 1050-1056.
20. Takase S, Pascarella L, Bergan JJ, et al. Hypertension-induced venous valve remodeling. J Vasc Surg 2004; 39: 1329-1334.
21. Hill A. The environment and disease: Association or causation? Proc R Soc Med 1965; 58: 295-300.
22. Forsén T, Eriksson J, Qiao Q, et al. Short stature and coronary heart disease: A 35-year follow-up of the Finnish cohorts of The Seven Countries Study. J Intern Med 2000; 248: 326-332.
23. Meijer K, Schulman S. The absence of 'minor' risk factors for recurrent venous thromboembolism: A systematic review of negative predictive values and negative likelihood ratios. J Thromb Haemost 2009; 7: 1619-1628.
24. Virnig BA, McBean M. Administrative data for public health surveillance and planning. Annu Rev Public Health 2001; 22: 213-230.